Index -
P/E -
EPS (ttm) -0.34
Insider Own 26.19%
Shs Outstand 188.63M
Perf Week -13.92%
Market Cap 495.56M
Forward P/E -
EPS next Y -0.22
Insider Trans -0.34%
Shs Float 179.30M
Perf Month -29.41%
Income -72.49M
PEG -
EPS next Q -0.07
Inst Own 25.86%
Short Float 6.47%
Perf Quarter -48.61%
Sales 82.06M
P/S 6.04
EPS this Y -20.24%
Inst Trans 24.39%
Short Ratio 2.79
Perf Half Y 14.61%
Book/sh 0.79
P/B 2.60
EPS next Y 11.88%
ROA -25.87%
Short Interest 11.60M
Perf Year 96.15%
Cash/sh 0.37
P/C 5.58
EPS next 5Y 3.28%
ROE -37.28%
52W Range 0.67 - 4.98
Perf YTD -34.62%
Dividend Est. -
P/FCF -
EPS past 5Y 66.40%
ROI -38.31%
52W High -59.04%
Beta 2.58
Dividend TTM -
Quick Ratio 2.41
Sales past 5Y 16.72%
Gross Margin 59.51%
52W Low 202.63%
ATR (14) 0.24
Dividend Ex-Date -
Current Ratio 3.99
EPS Y/Y TTM 47.32%
Oper. Margin -85.74%
RSI (14) 30.10
Volatility 8.42% 7.10%
Employees 190
Debt/Eq 0.14
Sales Y/Y TTM 24.51%
Profit Margin -88.35%
Recom 1.00
Target Price 5.00
Option/Short Yes / Yes
LT Debt/Eq 0.12
EPS Q/Q 60.17%
Payout -
Rel Volume 0.80
Prev Close 2.12
Sales Surprise 1.75%
EPS Surprise 37.50%
Sales Q/Q 35.33%
Earnings Feb 28 BMO
Avg Volume 4.16M
Price 2.04
SMA20 -19.02%
SMA50 -39.71%
SMA200 -14.51%
Trades
Volume 3,340,876
Change -3.77%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-17-25 Initiated
William Blair
Outperform
Sep-10-24 Initiated
Lake Street
Buy
$3
Mar-29-23 Initiated
UBS
Neutral
$2.25
Nov-29-22 Initiated
Oppenheimer
Outperform
$4.50
Oct-04-22 Initiated
B. Riley Securities
Buy
$9.50
Dec-17-21 Initiated
UBS
Neutral
$7
Jun-21-21 Initiated
Cowen
Outperform
$20
Apr-02-25 08:01AM
Mar-27-25 09:35AM
Mar-05-25 08:05AM
Feb-28-25 06:30AM
Feb-22-25 05:27PM
08:05AM
Loading…
Feb-21-25 08:05AM
Feb-18-25 08:05AM
Jan-29-25 09:10PM
04:01PM
Jan-24-25 07:53PM
(Insider Monkey) -5.80%
-7.44%
Jan-17-25 05:58PM
(PR Newswire) -5.41%
+6.54%
Jan-13-25 08:05AM
Jan-08-25 07:00AM
Dec-16-24 08:05AM
Dec-12-24 11:23AM
08:05AM
Loading…
Nov-11-24 08:05AM
Nov-08-24 10:25AM
Nov-07-24 08:05AM
Nov-01-24 06:30AM
Oct-28-24 08:00AM
Oct-18-24 08:05AM
Oct-08-24 11:11AM
Sep-17-24 08:00AM
Sep-09-24 10:07AM
Sep-04-24 10:08AM
08:30AM
Sep-03-24 04:30PM
08:30AM
Aug-28-24 04:30PM
Aug-20-24 09:00AM
04:05PM
Loading…
Aug-01-24 04:05PM
(Business Wire) -8.18%
+11.88%
Jul-18-24 08:05AM
Jun-27-24 09:00AM
Jun-24-24 07:00AM
May-28-24 08:30AM
May-16-24 02:13PM
May-15-24 08:30AM
May-02-24 10:43AM
May-01-24 08:56PM
04:05PM
Apr-23-24 08:00AM
Apr-17-24 08:00AM
Apr-15-24 08:30AM
Mar-27-24 09:00AM
Mar-20-24 08:00AM
Mar-19-24 08:30AM
Mar-15-24 05:35PM
Mar-06-24 08:30AM
Mar-05-24 09:40AM
Feb-29-24 11:36AM
Feb-28-24 04:05PM
Feb-23-24 08:00AM
Feb-22-24 08:00AM
Feb-15-24 04:15PM
(Business Wire) +10.78%
-6.19%
Feb-13-24 08:30AM
Jan-11-24 04:56PM
Jan-08-24 08:05AM
Jan-05-24 08:30AM
Dec-19-23 08:05AM
Dec-11-23 08:05AM
Nov-15-23 12:00PM
Nov-14-23 08:00AM
Nov-06-23 05:05PM
Nov-03-23 10:55AM
Nov-02-23 05:58PM
04:05PM
Oct-31-23 12:00PM
10:01AM
Oct-27-23 12:00PM
Oct-24-23 08:10AM
Oct-18-23 04:14PM
Oct-10-23 07:00AM
Oct-09-23 08:05AM
Oct-04-23 08:05AM
Sep-14-23 08:05AM
Sep-09-23 01:03AM
Aug-05-23 07:14AM
Aug-03-23 09:15AM
08:00AM
Aug-02-23 05:05PM
Jul-27-23 05:25PM
Jul-17-23 10:24AM
Jul-03-23 06:17AM
Jun-05-23 12:30PM
May-11-23 09:25AM
08:05AM
May-09-23 07:25PM
10:12AM
May-04-23 06:05PM
Apr-27-23 10:03AM
08:30AM
Apr-24-23 08:10AM
Apr-17-23 06:41AM
Apr-11-23 09:40AM
Apr-10-23 05:22PM
Apr-03-23 04:05PM
Mar-29-23 03:36PM
Mar-14-23 07:42AM
Mar-08-23 05:00PM
Mar-02-23 08:25AM
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stoica Andrei G Chief Technology Officer Apr 01 '25 Sale 2.17 1,805 3,908 1,600,182 Apr 03 05:24 PM Stoica Andrei G Officer Apr 01 '25 Proposed Sale 2.17 1,805 3,908 Apr 01 03:25 PM Stoica Andrei G Chief Technology Officer Mar 26 '25 Sale 2.69 3,354 9,016 1,601,987 Mar 28 04:26 PM Stoica Andrei G Officer Mar 26 '25 Proposed Sale 2.69 3,354 9,017 Mar 26 03:17 PM Stoica Andrei G Officer Dec 31 '24 Proposed Sale 3.30 1,680 5,536 Dec 31 03:16 PM Stoica Andrei G Chief Technology Officer Dec 24 '24 Sale 3.00 3,340 10,010 1,450,917 Dec 27 04:15 PM Getz Heather C EVP, CFO & COO Dec 20 '24 Sale 3.06 30,136 92,337 2,669,333 Dec 26 04:15 PM Cashman Steve Chief Business Officer Dec 20 '24 Sale 3.06 164,079 502,738 1,835,921 Dec 26 04:15 PM Stoica Andrei G Officer Dec 24 '24 Proposed Sale 3.00 3,340 10,011 Dec 26 09:58 AM Cashman Steve Officer Dec 20 '24 Proposed Sale 3.06 164,079 502,787 Dec 20 03:51 PM Getz Heather C Officer Dec 20 '24 Proposed Sale 3.06 30,136 92,346 Dec 20 03:43 PM Stoica Andrei G Chief Technology Officer Dec 05 '24 Sale 3.37 11,277 37,970 1,454,257 Dec 09 04:15 PM Stoica Andrei G Officer Dec 05 '24 Proposed Sale 3.37 11,277 37,969 Dec 05 03:17 PM Stoica Andrei G Chief Technology Officer Oct 01 '24 Sale 1.79 1,696 3,034 1,465,534 Oct 03 04:30 PM Stoica Andrei G Officer Oct 01 '24 Proposed Sale 1.79 1,696 3,034 Oct 01 03:28 PM Stoica Andrei G Chief Technology Officer Sep 24 '24 Sale 1.74 3,296 5,735 1,467,230 Sep 26 04:15 PM Stoica Andrei G Officer Sep 24 '24 Proposed Sale 1.74 3,296 5,734 Sep 24 03:10 PM Phanstiel S. Louise Director Sep 13 '24 Sale 1.96 60,049 117,792 0 Sep 13 04:15 PM S. Louise Phanstiel Director Sep 13 '24 Proposed Sale 1.93 60,049 115,895 Sep 13 04:06 PM Stoica Andrei G Chief Technology Officer Sep 05 '24 Sale 1.70 10,212 17,320 1,470,526 Sep 09 04:20 PM Stoica Andrei G Officer Sep 05 '24 Proposed Sale 1.70 10,212 17,321 Sep 05 03:37 PM ROBBINS LARRY Director Aug 30 '24 Buy 1.07 244,774 262,251 9,955,144 Sep 04 04:34 PM ROBBINS LARRY Director Aug 28 '24 Buy 0.98 1,246,950 1,221,382 9,280,451 Aug 30 04:18 PM ROBBINS LARRY Director Aug 29 '24 Buy 1.07 429,919 461,991 9,710,370 Aug 30 04:18 PM DEVIVO JOSEPH President & CEO Aug 07 '24 Buy 0.95 104,000 98,519 7,009,221 Aug 07 04:34 PM Stoica Andrei G Chief Technology Officer Jul 02 '24 Sale 0.87 1,703 1,487 1,480,738 Jul 05 04:00 PM Stoica Andrei G Chief Technology Officer Jun 25 '24 Sale 0.92 3,363 3,107 1,482,441 Jun 27 04:00 PM Stoica Andrei G Chief Technology Officer Jun 05 '24 Sale 0.90 11,754 10,602 1,485,804 Jun 07 05:50 PM Getz Heather C EVP, CFO & COO May 03 '24 Sale 0.95 59,848 57,035 2,699,469 May 07 04:15 PM
Index NDX, S&P 500
P/E 13.94
EPS (ttm) 4.34
Insider Own 0.27%
Shs Outstand 456.96M
Perf Week -24.37%
Market Cap 27.67B
Forward P/E 11.52
EPS next Y 5.25
Insider Trans -0.52%
Shs Float 456.08M
Perf Month -29.15%
Income 1.99B
PEG 1.49
EPS next Q 0.91
Inst Own 85.70%
Short Float 2.15%
Perf Quarter -22.80%
Sales 19.67B
P/S 1.41
EPS this Y 4.81%
Inst Trans 6.02%
Short Ratio 3.03
Perf Half Y -33.53%
Book/sh 18.49
P/B 3.27
EPS next Y 11.61%
ROA 6.08%
Short Interest 9.81M
Perf Year -32.03%
Cash/sh 6.32
P/C 9.57
EPS next 5Y 9.34%
ROE 25.60%
52W Range 70.45 - 94.80
Perf YTD -22.60%
Dividend Est. 0.10 (0.17%)
P/FCF 17.85
EPS past 5Y 5.31%
ROI 12.30%
52W High -36.17%
Beta 1.38
Dividend TTM 0.12 (0.21%)
Quick Ratio 0.79
Sales past 5Y 3.43%
Gross Margin 41.44%
52W Low -14.11%
ATR (14) 3.22
Dividend Ex-Date Apr 25, 2025
Current Ratio 1.00
EPS Y/Y TTM 43.28%
Oper. Margin 14.67%
RSI (14) 12.20
Volatility 4.86% 2.96%
Employees 53000
Debt/Eq 1.11
Sales Y/Y TTM 0.61%
Profit Margin 10.13%
Recom 1.60
Target Price 102.00
Option/Short Yes / Yes
LT Debt/Eq 0.92
EPS Q/Q 78.52%
Payout 2.88%
Rel Volume 5.21
Prev Close 72.00
Sales Surprise -0.23%
EPS Surprise 14.78%
Sales Q/Q 2.17%
Earnings Feb 13 BMO
Avg Volume 3.24M
Price 60.51
SMA20 -24.71%
SMA50 -29.10%
SMA200 -28.34%
Trades
Volume 16,884,642
Change -15.96%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-25 Upgrade
Goldman
Neutral → Buy
$85 → $100
Jan-08-25 Upgrade
Jefferies
Hold → Buy
$95 → $103
Sep-26-24 Downgrade
UBS
Neutral → Sell
$84 → $74
Sep-18-24 Upgrade
BTIG Research
Neutral → Buy
$100
Sep-09-24 Initiated
JP Morgan
Neutral
$90
Aug-06-24 Initiated
Stifel
Buy
$100
May-30-24 Initiated
Goldman
Neutral
$87
Feb-15-24 Initiated
HSBC Securities
Buy
$100
Feb-12-24 Upgrade
UBS
Sell → Neutral
$66 → $88
Nov-30-23 Initiated
Jefferies
Hold
$80
Nov-27-23 Downgrade
UBS
Neutral → Sell
$86 → $66
Sep-19-23 Initiated
Citigroup
Buy
$82
Aug-25-23 Initiated
Argus
Buy
$80
Aug-16-23 Initiated
Wells Fargo
Overweight
$90
Jul-31-23 Initiated
BofA Securities
Neutral
$82
Jun-27-23 Initiated
Morgan Stanley
Equal-Weight
$76
May-16-23 Initiated
Oppenheimer
Outperform
$97
Apr-26-23 Initiated
UBS
Neutral
$86
Apr-19-23 Initiated
Piper Sandler
Overweight
$95
Apr-10-23 Initiated
BTIG Research
Neutral
Show Previous Ratings
Apr-05-25 07:42AM
Apr-04-25 04:32PM
(Morningstar Research) -15.96%
12:03PM
Apr-03-25 02:43PM
01:15PM
10:29AM
Loading…
10:29AM
Apr-02-25 11:09AM
Apr-01-25 01:23PM
12:41PM
Mar-31-25 09:57AM
09:45AM
09:45AM
09:40AM
05:01AM
02:02AM
10:05AM
Loading…
Mar-29-25 10:05AM
Mar-28-25 01:41PM
08:37AM
Mar-27-25 04:14PM
11:34AM
09:00AM
06:15AM
Mar-26-25 05:07AM
Mar-24-25 10:47AM
10:12AM
09:40AM
Mar-23-25 12:00PM
Mar-22-25 02:29PM
Mar-20-25 12:52PM
08:00AM
05:10AM
Loading…
05:10AM
04:45AM
Mar-19-25 12:54PM
Mar-18-25 04:05PM
Mar-17-25 09:01AM
Mar-04-25 07:01PM
09:00AM
Feb-27-25 02:00AM
Feb-26-25 08:00AM
Feb-25-25 09:00AM
Feb-23-25 10:46AM
Feb-14-25 01:53PM
Feb-13-25 06:57PM
(Morningstar Research) +8.82%
06:20AM
Feb-11-25 09:00AM
Feb-10-25 09:00AM
Jan-31-25 03:00AM
Jan-29-25 08:04AM
07:30AM
Jan-28-25 08:00AM
Jan-22-25 04:05PM
(Investor's Business Daily)
03:46PM
(Investor's Business Daily)
12:00PM
(Investor's Business Daily)
10:53AM
(Investor's Business Daily)
Jan-21-25 04:04PM
(Investor's Business Daily)
Jan-15-25 09:00AM
Jan-14-25 09:25AM
Jan-08-25 04:30PM
Jan-03-25 06:46AM
Dec-12-24 08:00AM
Dec-05-24 09:00AM
Dec-04-24 09:15AM
09:00AM
Dec-03-24 08:00AM
Dec-01-24 11:45PM
12:30PM
09:00AM
Nov-30-24 07:20AM
06:05AM
Nov-26-24 09:00AM
Nov-25-24 09:00AM
Nov-22-24 09:09AM
Nov-21-24 04:54PM
06:00AM
Nov-18-24 08:00AM
Nov-13-24 08:00AM
Nov-12-24 08:13PM
10:00AM
Nov-11-24 06:00AM
Nov-07-24 09:31PM
04:58PM
08:00AM
Nov-03-24 01:37PM
Oct-31-24 06:57AM
02:58AM
Oct-30-24 06:20AM
Oct-24-24 12:16PM
Oct-21-24 12:10PM
12:10PM
Oct-18-24 02:30PM
09:20AM
Oct-17-24 09:00AM
Oct-16-24 12:38PM
Oct-14-24 09:00AM
Oct-09-24 09:00AM
Oct-08-24 08:46AM
(Investor's Business Daily)
08:00AM
Oct-07-24 09:00AM
02:30AM
Oct-06-24 01:24PM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Advanced Visualization Solutions segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company's history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Newcomb George A. Chief Accounting Officer Feb 18 '25 Sale 92.54 2,000 185,080 7,462 Feb 19 04:07 PM Rott Roland CEO, Imaging Nov 05 '24 Option Exercise 40.40 13,275 536,310 37,573 Nov 06 05:53 PM Rott Roland CEO, Imaging Nov 06 '24 Sale 86.48 3,577 309,339 24,298 Nov 06 05:53 PM Roland Rott Officer Nov 06 '24 Proposed Sale 86.48 3,577 309,330 Nov 06 05:45 PM Philip Rackliffe Officer Nov 05 '24 Proposed Sale 87.63 900 78,870 Nov 05 05:22 PM Rackliffe Philip CEO, AVS Nov 05 '24 Sale 87.63 900 78,867 12,715 Nov 05 04:06 PM Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Aug 14 '24 Sale 83.22 19,008 1,581,846 38,541 Aug 15 04:45 PM Kenneth Stacherski Officer Aug 14 '24 Proposed Sale 82.74 19,008 1,572,774 Aug 14 05:57 PM Jan Makela Officer Aug 12 '24 Proposed Sale 83.20 33,096 2,753,587 Aug 12 04:58 PM Westrick Thomas J. CEO, Patient Care Solutions Aug 07 '24 Sale 80.78 2,750 222,145 17,509 Aug 07 06:18 PM Thomas Westrick Officer Aug 07 '24 Proposed Sale 80.78 2,750 222,146 Aug 07 05:30 PM Kass-Hout Taha Chief Technology Officer May 28 '24 Sale 78.70 3,300 259,710 67,300 May 29 04:05 PM Makela Jan CEO, Imaging May 15 '24 Option Exercise 74.35 66,955 4,978,229 130,303 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Option Exercise 63.51 20,227 1,284,617 83,575 May 15 07:15 PM Makela Jan CEO, Imaging May 15 '24 Sale 81.54 66,955 5,459,511 63,348 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Sale 81.57 20,227 1,649,916 63,348 May 15 07:15 PM Jimenez Frank R GC & Corporate Secretary May 01 '24 Buy 76.52 1,315 100,624 75,796 May 02 06:00 AM
Index S&P 500
P/E 19.26
EPS (ttm) 3.16
Insider Own 0.86%
Shs Outstand 225.56M
Perf Week -0.75%
Market Cap 13.66B
Forward P/E 13.11
EPS next Y 4.64
Insider Trans -1.27%
Shs Float 222.47M
Perf Month -2.62%
Income 744.00M
PEG 2.49
EPS next Q 1.02
Inst Own 103.11%
Short Float 2.64%
Perf Quarter -15.17%
Sales 4.04B
P/S 3.38
EPS this Y 4.62%
Inst Trans -1.16%
Short Ratio 2.36
Perf Half Y -23.71%
Book/sh 21.16
P/B 2.88
EPS next Y 8.74%
ROA 8.65%
Short Interest 5.87M
Perf Year -21.50%
Cash/sh 8.79
P/C 6.92
EPS next 5Y 7.73%
ROE 15.78%
52W Range 59.06 - 84.67
Perf YTD -15.58%
Dividend Est. -
P/FCF 12.08
EPS past 5Y -
ROI 10.24%
52W High -28.12%
Beta 0.53
Dividend TTM -
Quick Ratio 2.78
Sales past 5Y 6.10%
Gross Margin 55.94%
52W Low 3.05%
ATR (14) 1.54
Dividend Ex-Date -
Current Ratio 3.49
EPS Y/Y TTM 50.25%
Oper. Margin 24.19%
RSI (14) 42.35
Volatility 2.86% 2.57%
Employees 7063
Debt/Eq 0.53
Sales Y/Y TTM 1.75%
Profit Margin 18.42%
Recom 2.48
Target Price 79.07
Option/Short Yes / Yes
LT Debt/Eq 0.52
EPS Q/Q -15.61%
Payout 0.00%
Rel Volume 2.62
Prev Close 61.69
Sales Surprise 0.00%
EPS Surprise 1.47%
Sales Q/Q 0.86%
Earnings May 01 AMC
Avg Volume 2.48M
Price 60.86
SMA20 -1.24%
SMA50 -5.58%
SMA200 -18.42%
Trades
Volume 6,508,673
Change -1.35%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-03-25 Downgrade
Argus
Buy → Hold
Feb-06-25 Downgrade
Leerink Partners
Outperform → Market Perform
$80 → $75
Feb-03-25 Downgrade
Needham
Buy → Hold
Dec-13-24 Initiated
Wolfe Research
Peer Perform
Dec-10-24 Reiterated
Needham
Buy
$90
Dec-10-24 Initiated
Jefferies
Hold
$85
Oct-01-24 Downgrade
Citigroup
Buy → Neutral
$95 → $85
Jun-27-24 Initiated
Stephens
Overweight
$87
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade
Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed
Cowen
Outperform
$83
Oct-14-21 Initiated
Redburn
Neutral
Show Previous Ratings
Apr-04-25 04:15PM
Apr-03-25 04:30PM
09:40AM
Mar-31-25 05:45PM
09:00AM
05:45PM
Loading…
Mar-24-25 05:45PM
Mar-20-25 11:46AM
Mar-19-25 09:57AM
09:00AM
Mar-17-25 05:45PM
Mar-13-25 06:58PM
Mar-10-25 05:01AM
Mar-07-25 11:30AM
09:00AM
Mar-04-25 07:37AM
04:01AM
Loading…
Feb-26-25 04:01AM
Feb-25-25 08:15AM
Feb-24-25 09:00AM
Feb-21-25 12:28PM
08:30AM
Feb-20-25 05:23AM
03:00AM
Feb-19-25 05:16AM
Feb-18-25 08:08AM
Feb-12-25 08:08AM
Feb-11-25 09:15AM
09:00AM
08:12AM
Feb-07-25 09:40AM
07:21AM
09:50AM
Loading…
Feb-06-25 09:50AM
09:34AM
08:05AM
(Thomson Reuters StreetEvents)
02:13AM
Feb-05-25 05:30PM
05:15PM
04:11PM
(Associated Press Finance)
04:11PM
04:01PM
Feb-04-25 09:40AM
Jan-31-25 09:15AM
09:00AM
Jan-29-25 10:01AM
Jan-28-25 05:45PM
Jan-22-25 05:45PM
Jan-21-25 08:00AM
Jan-20-25 09:00AM
Jan-16-25 06:38AM
Jan-14-25 05:45PM
Jan-12-25 04:00PM
Jan-08-25 05:45PM
Jan-07-25 04:04PM
09:00AM
Jan-06-25 04:15PM
08:05AM
Jan-03-25 06:46AM
Jan-02-25 05:45PM
Dec-26-24 05:45PM
Dec-24-24 09:00AM
Dec-23-24 12:19PM
Dec-19-24 05:45PM
06:45AM
Dec-18-24 08:08AM
Dec-14-24 06:50AM
Dec-13-24 07:10PM
05:45PM
09:00AM
Dec-10-24 11:10PM
04:01PM
Dec-09-24 04:05PM
08:05AM
Dec-04-24 11:30AM
Dec-02-24 01:29PM
08:08AM
Nov-25-24 08:22AM
Nov-19-24 09:00AM
Nov-14-24 08:08AM
Nov-08-24 12:21PM
09:00AM
Nov-05-24 11:43AM
(Morningstar Research) -5.88%
06:35AM
(Thomson Reuters StreetEvents)
02:06AM
Nov-04-24 05:30PM
05:15PM
04:20PM
(Associated Press Finance)
04:01PM
Oct-30-24 09:15AM
Oct-28-24 05:45PM
10:01AM
06:18AM
Oct-25-24 02:57PM
Oct-23-24 09:00AM
06:00AM
Oct-21-24 05:45PM
Oct-15-24 05:45PM
08:05AM
07:32AM
07:02AM
Oct-14-24 02:07PM
08:05AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mitchell Essex D Chief Operating Officer Dec 04 '24 Option Exercise 62.60 22,902 1,433,659 52,813 Dec 06 04:28 PM Mitchell Essex D Chief Operating Officer Dec 04 '24 Sale 76.34 24,856 1,897,482 27,957 Dec 06 04:28 PM Mitchell Essex D Officer Dec 04 '24 Proposed Sale 76.34 24,856 1,897,484 Dec 04 12:24 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Option Exercise 40.95 32,805 1,343,214 136,721 Sep 03 04:15 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Sale 80.56 52,679 4,243,662 84,042 Sep 03 04:15 PM Oberton Karleen Marie Officer Aug 29 '24 Proposed Sale 80.56 52,679 4,243,657 Aug 29 04:36 PM Schnittker Brandon Div. President, GYN Surgical Aug 06 '24 Sale 83.11 476 39,559 3,735 Aug 08 04:08 PM Schnittker Brandon Officer Aug 06 '24 Proposed Sale 83.11 476 39,559 Aug 06 04:48 PM COHN BENJAMIN JORDAN Principal Accounting Officer Aug 01 '24 Sale 81.99 5,093 417,570 10,476 Aug 05 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Option Exercise 26.21 44,039 1,154,262 1,201,601 Aug 01 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Sale 81.70 44,039 3,597,924 1,157,562 Aug 01 04:09 PM COHN BENJAMIN JORDAN Officer Aug 01 '24 Proposed Sale 81.99 5,093 417,574 Aug 01 03:58 PM MACMILLAN STEPHEN P Officer Jul 30 '24 Proposed Sale 81.70 44,039 3,597,894 Jul 30 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Option Exercise 26.21 3,672 96,243 1,161,234 Jul 19 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Sale 80.13 3,672 294,223 1,157,562 Jul 19 04:09 PM Stamoulis Christiana Director Jul 17 '24 Option Exercise 26.74 9,039 241,703 54,511 Jul 19 04:06 PM Stamoulis Christiana Director Jul 17 '24 Sale 79.50 9,039 718,600 45,472 Jul 19 04:06 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite